Student startup GiftAMeal gaining national attention

Student startup GiftAMeal gaining national attention

The buzz continues about GiftAMeal, a startup incubated with the help of Washington University students. The venture had two wins at the RECESS Pitch Competition in Los Angeles: the Audience Choice Award and an award for best explanation video. The startup also locked in its first major corporate deal.
Lagieski looks to punch ticket to Rio

Lagieski looks to punch ticket to Rio

Michael Lagieski, a senior in the School of Engineering & Applied Science and a member of the Washington University swim team, will attempt to qualify for the U.S. Olympic Swim Team in the 100-meter breaststroke June 26 in Omaha, Neb.
Age, obesity, dopamine appear to influence preference for sweet foods

Age, obesity, dopamine appear to influence preference for sweet foods

As young people reach adulthood, preferences for sweet foods typically decline. But for people with obesity, research from the School of Medicine suggests that the drop-off may not be as steep and that the brain’s reward system operates differently in obese people than in thinner people. The findings are published in the journal Diabetes.
New insight into role of amyloid beta in Alzheimer’s disease

New insight into role of amyloid beta in Alzheimer’s disease

New Alzheimer’s disease research details a technique that speedily measures levels in the brain of a damaging protein fragment, and insight into why mutations in a specific gene increase the risk of developing the disease. Both studies, from researchers at Washington University School of Medicine in St. Louis, are available online in The Journal of Experimental Medicine.
Probing proteins’ 3-D structures suggests existing drugs may work for many cancers

Probing proteins’ 3-D structures suggests existing drugs may work for many cancers

Examining databases of proteins’ 3-D shapes, scientists at School of Medicine have identified more than 850 DNA mutations that appear to be linked to cancer. The information may expand the number of cancer patients who can benefit from existing drugs. The study, published June 13 in Nature Genetics, detailed a list of the mutations and associated drugs that may work against them.
View More Stories